These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10380065)

  • 1. Communication regarding adverse drug reactions between secondary and primary care: a postal questionnaire survey of general practitioners.
    Green CF; Mottram DR; Pirmohamed M; Horner R; Rowe PH
    J Clin Pharm Ther; 1999 Apr; 24(2):133-9. PubMed ID: 10380065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudinal survey of voluntary reporting of adverse drug reactions.
    Eland IA; Belton KJ; van Grootheest AC; Meiners AP; Rawlins MD; Stricker BH
    Br J Clin Pharmacol; 1999 Oct; 48(4):623-7. PubMed ID: 10583035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postdischarge adverse drug reactions in primary care originating from hospital care in France: a nationwide prospective study.
    Letrilliart L; Hanslik T; Biour M; Fagot JP; Guiguet M; Flahault A
    Drug Saf; 2001; 24(10):781-92. PubMed ID: 11676305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reporting of adverse drug reactions by general practitioners: a questionnaire-based study in the Netherlands.
    Passier A; ten Napel M; van Grootheest K; van Puijenbroek E
    Drug Saf; 2009; 32(10):851-8. PubMed ID: 19722728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adverse drug reaction reporting in emergency medicine].
    Milojevic K; Chassagnol I; Brion N; Cléro J; Degrèze N; Lambert Y
    Therapie; 2004; 59(6):611-4. PubMed ID: 15789824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Satisfaction of a pharmacovigilance declaration support network in general practice].
    Driot D; Figuet L; Birebent J; Coste S; Durrieu G; Jacquot J; Bismuth M
    Therapie; 2018 Dec; 73(6):483-493. PubMed ID: 29921459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.
    Tabali M; Ostermann T; Jeschke E; Witt CM; Matthes H
    J Manag Care Pharm; 2012; 18(6):427-38. PubMed ID: 22839683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom.
    Belton KJ; Lewis SC; Payne S; Rawlins MD; Wood SM
    Br J Clin Pharmacol; 1995 Mar; 39(3):223-6. PubMed ID: 7619660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of documentation of patient reported adverse drug reactions on both paper-based medication charts and electronic medication charts at a New Zealand hospital.
    Shen W; Wong B; Chin JY; Lee M; Coulter C; Braund R
    N Z Med J; 2016 Oct; 129(1444):90-96. PubMed ID: 27806032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of adverse drug reactions through the minimum basic data set.
    Salmerón-García A; Cabeza Barrera J; Vergara Pavón MJ; Román Márquez E; Cortés de Miguel S; Vallejo-Rodríguez I; Raya García S; Casado Fernández E
    Pharm World Sci; 2010 Jun; 32(3):322-8. PubMed ID: 20213432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Views of British community pharmacists on direct patient reporting of adverse drug reactions (ADRs).
    Krska J
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1130-3. PubMed ID: 22729956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes to adverse drug reaction reporting in the Northern Region.
    Bateman DN; Sanders GL; Rawlins MD
    Br J Clin Pharmacol; 1992 Nov; 34(5):421-6. PubMed ID: 1467137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge, attitude and practice of General Practitioners towards adverse drug reaction reporting in South of Iran, Shiraz (Pharmacoepidemiology report).
    Peymani P; Tabrizi R; Afifi S; Namazi S; Heydari ST; Shirazi MK; Nouraei H; Sadeghi E; Lankarani KB; Maharlouei N
    Int J Risk Saf Med; 2016 Mar; 28(1):25-31. PubMed ID: 27176754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public confidence in ADR identification and their views on ADRreporting: mixed methods study.
    Jarernsiripornkul N; Patsuree A; Krska J
    Eur J Clin Pharmacol; 2017 Feb; 73(2):223-231. PubMed ID: 27837337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting of adverse drug reactions by hospital doctors and the response to intervention.
    McGettigan P; Golden J; Conroy RM; Arthur N; Feely J
    Br J Clin Pharmacol; 1997 Jul; 44(1):98-100. PubMed ID: 9241104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists.
    Generali JA; Danish MA; Rosenbaum SE
    Ann Pharmacother; 1995 Apr; 29(4):365-9. PubMed ID: 7633012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient reporting of potential adverse drug reactions: a methodological study.
    Jarernsiripornkul N; Krska J; Capps PA; Richards RM; Lee A
    Br J Clin Pharmacol; 2002 Mar; 53(3):318-25. PubMed ID: 11874396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adverse drug reaction reporting assignment for specialist oncology nurses: a preliminary evaluation of quality, relevance and educational value in a prospective cohort study.
    Schutte T; van Eekeren R; Richir M; van Staveren J; van Puijenbroek E; Tichelaar J; van Agtmael M
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Jan; 391(1):17-26. PubMed ID: 29063137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.